Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
28,649
Value
$900.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CPRX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,649$900.4K<0.1%+10,639+59.1%AddedHolders
Q1 202618,010$445.9K<0.1%−4,489−20.0%ReducedHolders
Q4 202522,499$525.1K<0.1%+702+3.2%AddedHolders
Q3 202521,797$429.4K<0.1%−4,024−15.6%ReducedHolders
Q2 202525,821$560.3K<0.1%−772−2.9%ReducedHolders
Q1 202526,593$644.9K<0.1%−7,106−21.1%ReducedHolders
Q4 202433,699$703.3K<0.1%+10,379+44.5%AddedHolders
Q3 202423,320$463.6K<0.1%+6,158+35.9%AddedHolders
Q2 202417,162$265.8K<0.1%−5,295−23.6%ReducedHolders
Q1 202422,457$358.0K<0.1%+3,614+19.2%AddedHolders
Q4 202318,843$316.8K<0.1%+3,564+23.3%AddedHolders
Q3 202315,279$178.6K<0.1%+192+1.3%AddedHolders
Q2 202315,087$202.8K<0.1%+1,056+7.5%AddedHolders
Q1 202314,031$232.6K<0.1%−1,243−8.1%ReducedHolders
Q4 202215,274$284.1K<0.1%+2,027+15.3%AddedHolders
Q3 202213,247$169.0K<0.1%+2,484+23.1%AddedHolders
Q2 202210,763$75.0K<0.1%−7,445−40.9%ReducedHolders
Q1 202218,208$151.0K<0.1%−3,008−14.2%ReducedHolders
Q4 202121,216$143.0K<0.1%+8,774+70.5%AddedHolders
Q3 202112,442$66.0K<0.1%−12,748−50.6%ReducedHolders
Q2 202125,190$145.0K<0.1%−743−2.9%ReducedHolders
Q1 202125,933$120.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.